ArticleCancer immunology research2022

Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.

Sanghyun P Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.